Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older
- You have already had an in-clinic evaluation for blood in the urine, which included at least one of the following: a CT scan, an ultrasound, or a cystoscopy (a camera examination of the bladder)
Who may not be able to join:
- You have been diagnosed with a cancer other than the one being studied in this trial within the past 5 years (note: common skin cancers do not count against this; if your history is unknown or unavailable, you may still be eligible)
- You have bladder cancer that has come back and grown into the muscle wall of the bladder
- You have ever been diagnosed with a type of cancer in the upper urinary tract (kidneys or ureters) before having bladder surgery
- You have received chemotherapy for a cancer other than the one being studied in this trial within the past 5 years
- You have had radiation treatment directed at the area being studied in this trial
- You have had a tissue biopsy of the organ or area being studied within the 3 days before the urine sample is collected
- You have had your bladder surgically removed
- You have had a urinary catheter (a tube placed into the bladder to drain urine) inserted within the past 7 days before urine collection
- You have had a urinary tract infection within the past 14 days before urine collection
- You currently have a long-term urinary catheter in place
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: John B. Kisiel, MD, Mayo Clinic in Rochester
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Blood sample to support the development of non-invasive tests for early detection of bladder cancer; Urine sample to support the development of non-invasive tests for early detection of bladder cancer
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.